CD8A and non-small cell lung carcinoma: In addition, RTs generally demonstrate significantly lower CD8+ cytotoxic T lymphocyte (CTL) density and lower CD68+ macrophage density, with a loss of tertiary lymphoid structure (TLS) in patients with NSCLC who have received platinum-based chemotherapy postoperatively.